• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$34.56 $0.30 (0.88%)

REAL-TIME: Last trade at

Genomic Health

NASDAQ:GHDX

Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 2

FDA Nod for Cepheid's Infinity-80 - Analyst Blog

Myriad in Research Partnership - Analyst Blog

Genomic Health Stays Neutral - Analyst Blog

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABP

Myriad Reiterated Neutral - Analyst Blog

3 Stocks Near 52-Week Highs Worth Selling

Three Small Cap Companies Doing Well and Doing Good

Cepheid Back to Neutral - Analyst Blog

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CY

Will Mayo v. Prometheus Fire Up Pharma?: Kevin DeGeeter

Genomic Health Beats Estimates - Analyst Blog

Myriad Beats, Raises Guidance - Analyst Blog

Cepheid Upgraded to Outperform - Analyst Blog

Positive Data from Genomic Health - Analyst Blog

Myriad: Prolaris a Useful Test - Analyst Blog

Reiterating Genomic at Neutral - Analyst Blog

Reiterating Cepheid at Neutral - Analyst Blog

Genomic Misses, Grows Annually - Analyst Blog

Genomic Health Meets on Revenues, Misses on EPS

Myriad Beats, Raises Guidance - Analyst Blog

Genomic's Useful Colon Cancer Test - Analyst Blog

Myriad Gets Rights to RAD51C Gene - Analyst Blog

Amass a Fortune With These Stocks

Genomic Looks to Diversify Offering (revised) - Analyst Blog

Genomic Looks to Diversify Offering - Analyst Blog

Myriad Reverts to Neutral - Analyst Blog

Ideas: 10 Stocks With Rising Gross Profit Margins and Insider Buying

Myriad Bracanalysis Proves Cheaper - Analyst Blog

Genomic Health to Sell Test to Predict Breast Cancer Recurrence

Genomic DCIS Score Coming Shortly - Analyst Blog

Genomic Health to Showcase Key Data - Analyst Blog

A Simplified ASCO 2011 List for Biotech Investor Research

Analyst Calls: AOL, BG, CCL, CP, CSX, HRS, NE, OC, PHM, RIG, SBUX, TXT ...

7 Stocks With New Insider Buying

Top 15 Healthcare Stocks With Bearish Options Sentiment

20 Rallies That Analysts Think Will Continue

Friday's Top Volume Gainers With Bullish Options Sentiment

5 Heavily Shorted Stocks With Significant Insider Buying

Top 13 Insider Buys

See More Articles...